Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...
Catalent, Inc., the leader in enabling the development and supply of better treatments for patients worldwide, today ...
Spain's Naturgy plans to buy back almost 2.5-billion euros ($2.6 billion) of its shares, up to 10% of its capital, then ...
Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback